HR 3203
117th Congress
House
Health
Cardiovascular and respiratory health
Emergency medical services and trauma care
Health care coverage and access
Health facilities and institutions
Health programs administration and funding
Home and outpatient care
Hospital care
Infectious and parasitic diseases
Inflation and prices
Prescription drugs
To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Introduced: May 13, 2021
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2021
Referred to the Subcommittee on Health.
May 13, 2021
Referred to the House Committee on Energy and Commerce.
May 13, 2021
Introduced in House
Plain-English summary
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2